Disability and health status in patients with chronic inflammatory demyelinating polyneuropathy

References

• Mendell J R. Chronic inflammatory demyelinating polyradiculoneuropathy. Annu Rev Med 1993; 211–219
   PubMed Web of Science ®Google Scholar
• Latov N. Diagnosis of CIDP. Neurology 2002; 59: S2–S6
   PubMed Web of Science ®Google Scholar
• Rotta F T, Sussman A T, Bradley W G, Ayyar D R, Sharma K R, Shebert R T. The spectrum of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 2000; 173: 129–139
   PubMed Web of Science ®Google Scholar
• Pollard J D. Chronic inflammatory demyelinating polyradiculoneuropathy. Curr Opin Neurol 2002; 15: 279–283
   PubMed Web of Science ®Google Scholar
• Choudhary P P, Hughes R A. Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin. QJM: Mon J Assoc Physicians 1995; 88: 493–502
   PubMed Web of Science ®Google Scholar
• McLeod J G, Pollard J D, Macaskill P, Mohamed A, Spring P, Khurana V. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol 1999; 46: 910–913
   PubMed Web of Science ®Google Scholar
• Mygland A, Monstad P. Chronic polyneuropathies in Vest-Agder, Norway. Eur J Neurol 2001; 8: 157–165
   PubMed Web of Science ®Google Scholar
• Hadden R D, Hughes R A. Management of inflammatory neuropathies. J Neurol Neurosurg Psychiatry 2003; 74: ii9–ii14
   PubMed Web of Science ®Google Scholar
• Dyck P J, O'Brien P C, Oviatt K F, Dinapoli R P, Daube J R, Bartleson J D, Mokri B, Swift T, Low P A, Windebank A J. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 1982; 11: 136–141
   PubMed Web of Science ®Google Scholar
• Mehndiratta M M, Hughes R AC. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database of Syst Rev 2002, Issue 1. Art No.: CD002062. DOI: 10.1002/14651868.CD002062
   PubMedGoogle Scholar
• Erdmann P G, van Meeteren N LU, Kalmijn S, Wokke J HJ, Helders P JM, van den Berg L H. Functional health status of patients with chronic inflammatory neuropathies. J Peripher Nerv Syst 2005; 10: 181–189
   PubMed Web of Science ®Google Scholar
• Krupp L B, Alvarez L A, LaRocca N G, Scheinberg L C. Fatigue in multiple sclerosis. Arch Neurol 1988; 45: 435–437
   PubMed Web of Science ®Google Scholar
• Merkies I SJ, Schmitz P IM, Samijn J PA, van der Meché F GA, van Doorn P A. Fatigue in immune-mediated polyneuropathies. European inflammatory neuropathy cause and treatment (INCAT) group. Neurology 1999; 53: 1648–1654
   PubMed Web of Science ®Google Scholar
• Merkies I SJ, Schmitz P IM, van der Meché F GA, Samijn J PA, van Doorn P A. for the Inflammatory Neuropathy Cause and Treatment (INCAT) group. Quality of life complements traditional outcome measures in immune-mediated polyneuropathies. Neurology 2002; 59: 84–91
   PubMed Web of Science ®Google Scholar
• Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. 1991
   Google Scholar
• Wiles P G, Pearce S M, Rice P J, Mitchell J M. Vibration perception threshold: influence of age, height, sex, and smoking, and calculation of accurate centile values. Diabet Med 1991; 8: 157–161
   PubMed Web of Science ®Google Scholar
• Krupp L B, LaRocca N G, Muir-Nash J, Steinberg A D. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121–1123
   PubMed Web of Science ®Google Scholar
• Krupp L B, Coyle P K, Doscher C, Miller A, Cross A H, Jandorf L, Halper J, Johnson B, Morgante L, Grimson R. Fatigue therapy in multiple sclerosis: results of a double-blind, randomised, parallel trial of amantadine, pemoline, and placebo. Neurology 1995; 45: 1956–1961
   PubMed Web of Science ®Google Scholar
• Krupp L B, LaRocca N G, Muir J, Steinberg A D. A study of fatigue in systemic lupus erythematosus. J Rheumatol 1990; 17: 1450–1452
   PubMed Web of Science ®Google Scholar
• Lerdal A, Wahl A, Rustoen T, Hanestad B R, Moum T. Fatigue in the general population: a translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scand J Public Health 2005; 33: 123–130
   PubMed Web of Science ®Google Scholar
• Berg K O, Wood-Dauphinee S L, Williams J I, Maki B. Measuring balance in the elderly: validation of an instrument. Can J Public Health Revue Canadienne De Sante Publique 1992; 83: S7–S11
   PubMed Web of Science ®Google Scholar
• Berg K, Wood-Dauphinee S, Williams J I. The balance scale: reliability assessment with elderly residents and patients with an acute stroke. Scand J Rehabil Med 1995; 27: 27–36
   PubMedGoogle Scholar
• Mathiowetz V, Weber K, Kashman N, Volland G. Adult norms for the nine hole peg test of finger dexterity. Occup Ther J Res 1985; 5: 24–38
   Web of Science ®Google Scholar
• Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991; 39: 142–148
   PubMed Web of Science ®Google Scholar
• Sullivan M, Karlsson J. The Swedish SF-36 health survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol 1998; 51: 1105–1113
   PubMed Web of Science ®Google Scholar
• Sullivan M, Karlsson J, Taft C, Ware J. SF-36 Hälsoenkät: svensk manual och tolkningsguide. Sahlgrenska University Hospital, Gotenburg 2002
   Google Scholar
• Bohannon R W. Reference values for the Timed Up and Go test: a descriptive meta-analysis. J Geriatr Phys Ther 2006; 29: 64–68
   PubMedGoogle Scholar
• Berg K, Wood-Dauphinée S, Williams J I, Gayton D. Measuring balance in the elderly: preliminary development of an instrument. Physiother Can 1989; 41: 304–311
   Google Scholar
• Ruhland J L, Shields R K. The effects of a home exercise program on impairment and health-related quality of life in persons with chronic peripheral neuropathies. Phys Ther 1997; 77: 1026–1039
   PubMed Web of Science ®Google Scholar
• Garssen M, Bussman J, Schmitz P, Zandbergen A, Welter T. Physical training and fatigue, fitness, and quality of life in Guillain-Barré syndrome and CIDP. Neurology 2004; 63: 2393–2395
   PubMed Web of Science ®Google Scholar